Inna Ovsyannikova is the Director of Laboratory-based Studies for Mayo Clinic Vaccine Research Group and a Professor of Medicine at Mayo Clinic.
Dr. Ovsyannikova brings a comprehensive, systems-level understanding of how age, race, and sex affect innate and adaptive immunity, particularly regarding measles, mumps, rubella, and influenza vaccine response.
She is a leading researcher in the field of age-related changes and defects in the regulation and function of immune responses to the influenza vaccine virus in elderly persons. Dr. Ovsyannikova’s current research is focused on the immune responses to the SARS-CoV-2 virus and the development of a COVID-19 peptide-based vaccine.
She has published over 220 scientific manuscripts and 15 books/book chapters and has participated in more than 180 scientific exhibits and presentations at national and international societies.
Dr. Ovsyannikova is the Associate Editor of Vaccine and also holds current membership in the American Association of Immunologists and the American Society for Microbiology. She has served on many National Institutes of Health (NIH) study sections and international review panels.
Dr. Ovsyannikova received her Ph.D. degree from the Ilya Mechnikov Research Institute for Vaccines and Sera in Moscow, Russia, and completed her postdoctoral training at the University of Virginia and has two fellowships in Clinical Pharmacology and Vaccinology at Mayo Clinic.